Conductive hyperthermic chemotherapy versus electromotive drug administration of mitomycin C as intravesical adjuvant treatment of patients with intermediate or high-risk non-muscle invasive bladder cancer-Reference-Cited by-同舟云学术

Conductive hyperthermic chemotherapy versus electromotive drug administration of mitomycin C as intravesical adjuvant treatment of patients with intermediate or high-risk non-muscle invasive bladder cancer

Published:2023-02 Issue:2 Volume:41 Page:109.e1-109.e8
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Melgarejo Segura María Teresa,Morales Martínez Ana,Yáñez Castillo Yaiza,Arrabal Polo Miguel Ángel,Gómez Lechuga Pablo,Pareja Vílchez Manuel,Arrabal Martín Miguel

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Professionals SO. EAU Guidelines: Non-muscle-invasive Bladder Cancer. Uroweb, https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/; [accessed 08.11.21].

2. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

3. Recurrence Rate and Cost Consequence of the Shortage of Bacillus Calmette-Guérin Connaught Strain for Bladder Cancer Patients;Ourfali;Eur Urol Focus,2021

4. Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model;Fernandez-Gomez;J Urol,2009

5. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive Bladder Cancer: a systematic review;Lammers;Eur Urol,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of conduction hyperthermia in the treatment of non-muscle invasive bladder cancer: A systematic review;Urologic Oncology: Seminars and Original Investigations;2024-09

2. Perfusion drugs for non‑muscle invasive bladder cancer (Review);Oncology Letters;2024-04-15

3. Mitomycin;Reactions Weekly;2024-03-23

4. Local Drug Delivery in Bladder Cancer: Advances of Nano/Micro/Macro-Scale Drug Delivery Systems;Pharmaceutics;2023-12-03

5. Device-assisted intravesical chemotherapy versus bacillus Calmette–Guerin for intermediate or high-risk non-muscle invasive bladder cancer: a systematic reviewer and meta-analysis;International Urology and Nephrology;2023-09-02